STADA Asia Pacific
Historically STADA’s business in the APAC region has been highly fragmented. We’ve had different commercial models and vastly different product portfolios across each market. In the past two years however, we’ve invested heavily in restructuring and rebuilding our organisation. This is enabling us to leverage many of the recent STADA global acquisitions, to substantially expand our portfolio in the APAC region.
We take an agile & opportunistic approach from market to market; this includes commercialisation by our own entities, in- & out-licensing and even local acquisitions, and is in line with STADA’s corporate strategy of being the go-to-partner of choice, particularly in Consumer Healthcare & Generics. Our industry is changing on an almost daily basis, as the Covid-19 pandemic continues to shape the way we conduct business and connect with each other.
Now more than ever our values serve to guide us, as we act with integrity, agility, entrepreneurship and as OneSTADA, caring for people’s health as a trusted partner!